Lifevantage (NASDAQ:LFVN) Releases Earnings Results, Beats Estimates By $0.01 EPS

Lifevantage (NASDAQ:LFVN) announced its quarterly earnings results on Tuesday. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01, Zacks reports. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%. Lifevantage updated its FY 2026 guidance to 1.000-1.150 EPS.

Lifevantage Stock Down 4.6%

LFVN traded down $0.34 during midday trading on Tuesday, reaching $7.00. The company had a trading volume of 331,180 shares, compared to its average volume of 187,016. The business has a 50-day moving average of $10.13 and a two-hundred day moving average of $11.85. The company has a market cap of $88.84 million, a P/E ratio of 9.46 and a beta of 0.26. Lifevantage has a 1 year low of $6.97 and a 1 year high of $27.38.

Lifevantage Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 16th. Shareholders of record on Monday, September 8th were given a $0.045 dividend. The ex-dividend date was Monday, September 8th. This represents a $0.18 dividend on an annualized basis and a yield of 2.6%. Lifevantage’s dividend payout ratio is presently 24.32%.

Insider Buying and Selling

In other Lifevantage news, Director Michael A. Beindorff sold 4,125 shares of the company’s stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $11.44, for a total value of $47,190.00. Following the completion of the sale, the director owned 22,858 shares in the company, valued at $261,495.52. This represents a 15.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 21.95% of the stock is currently owned by insiders.

Institutional Trading of Lifevantage

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Wasatch Advisors LP increased its position in Lifevantage by 6.6% in the second quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after buying an additional 27,765 shares in the last quarter. Geode Capital Management LLC increased its position in Lifevantage by 106.1% in the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after buying an additional 126,274 shares in the last quarter. Squarepoint Ops LLC increased its position in Lifevantage by 68.1% in the second quarter. Squarepoint Ops LLC now owns 70,507 shares of the company’s stock worth $922,000 after buying an additional 28,574 shares in the last quarter. Man Group plc increased its position in Lifevantage by 72.5% in the second quarter. Man Group plc now owns 53,098 shares of the company’s stock worth $695,000 after buying an additional 22,319 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Lifevantage in the second quarter worth about $597,000. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on LFVN shares. Wall Street Zen cut Lifevantage from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Lifevantage in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Lifevantage currently has an average rating of “Moderate Buy” and an average target price of $30.50.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.